Login to Your Account



Other News To Note


Tuesday, September 11, 2012
• Arsanis Biosciences GmbH, of Vienna, Austria, said it received two grants involving the Austrian Research Promotion Agency (Osterr. Forschungsforderungs GmbH, or FFG) to support development of monoclonal antibody drugs against nosocomial infections.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription